![The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis | British Journal of Ophthalmology The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis | British Journal of Ophthalmology](https://bjo.bmj.com/content/bjophthalmol/89/11/1442/F3.large.jpg?width=800&height=600&carousel=1)
The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis | British Journal of Ophthalmology
![Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic - ScienceDirect Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1091853121005577-gr1.jpg)
Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic - ScienceDirect
Temporary Improvement From Unintentional Ptosis Secondary To Botulinum Toxin Injection By 5 % Phenylephrine Plus 0.075 % Brimonidine Eye-Drop: A Case Series
![Cureus | Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases | Media Cureus | Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases | Media](https://assets.cureus.com/uploads/figure/file/562762/article_river_19f30830ae5e11ed8b4b67dc2868a88d-Picture2.png)
Cureus | Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases | Media
Temporary Improvement From Unintentional Ptosis Secondary To Botulinum Toxin Injection By 5 % Phenylephrine Plus 0.075 % Brimonidine Eye-Drop: A Case Series
![Eyelid ptosis following botulinum toxin injection treated with brimonidine 0.33% topical gel - ScienceDirect Eyelid ptosis following botulinum toxin injection treated with brimonidine 0.33% topical gel - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352512622000595-gr2.jpg)